112 related articles for article (PubMed ID: 8088486)
1. [Ovarian hyperstimulation syndrome].
Keck C; Neulen J; Breckwoldt M
Geburtshilfe Frauenheilkd; 1994 Jun; 54(6):315-20. PubMed ID: 8088486
[TBL] [Abstract][Full Text] [Related]
2. [Ovarian hyperstimulation syndrome in medically assisted reproduction].
Rogé P; Erny R
Rev Fr Gynecol Obstet; 1994 Oct; 89(10):495-501. PubMed ID: 7817078
[TBL] [Abstract][Full Text] [Related]
3. [Ovarian hyperstimulation syndrome--a risk of treatment for infertility].
Bangsbøll S
Nord Med; 1997 Sep; 112(7):236-9. PubMed ID: 9380489
[TBL] [Abstract][Full Text] [Related]
4. [Update on ovarian hyperstimulation syndrome].
Delbaere A; Rodesch C; Englert Y
Rev Med Brux; 1995 Nov; 16(5):354-60. PubMed ID: 7501911
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of low dose hCG for luteal support after triggering ovulation with a GnRH agonist in cases of polyfollicular development.
Krause BT; Ohlinger R
Eur J Obstet Gynecol Reprod Biol; 2006 May; 126(1):87-92. PubMed ID: 16377065
[TBL] [Abstract][Full Text] [Related]
6. Ovarian hyperstimulation syndrome in gonadotropin-treated laboratory South African clawed frogs (Xenopus laevis).
Green SL; Parker J; Davis C; Bouley DM
J Am Assoc Lab Anim Sci; 2007 May; 46(3):64-7. PubMed ID: 17487957
[TBL] [Abstract][Full Text] [Related]
7. [Ovarian hyperstimulation in medically assisted reproduction: which practical approach?].
Priou G
Contracept Fertil Sex; 1996 Sep; 24(9):647-9. PubMed ID: 8998510
[TBL] [Abstract][Full Text] [Related]
8. Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles.
Papanikolaou EG; Pozzobon C; Kolibianakis EM; Camus M; Tournaye H; Fatemi HM; Van Steirteghem A; Devroey P
Fertil Steril; 2006 Jan; 85(1):112-20. PubMed ID: 16412740
[TBL] [Abstract][Full Text] [Related]
9. [Research on the protocol of limited ovarian stimulation to prevent ovarian hyperstimulation syndrome].
Zhu YM; Gao HJ; He RH; Huang HF
Zhonghua Fu Chan Ke Za Zhi; 2006 Nov; 41(11):740-4. PubMed ID: 17327030
[TBL] [Abstract][Full Text] [Related]
10. Ovarian hyperstimulation syndrome (OHS): a case of severe OHS.
Rubessa S; Omodei U; Falsetti L; Gastaldi A
Acta Eur Fertil; 1989; 20(1):15-7. PubMed ID: 2476905
[TBL] [Abstract][Full Text] [Related]
11. [Treatment and prevention of the ovarian hyperstimulation syndrome].
Morán C; Ortega E; Fiorelli S; Murillo A; Zárate A
Ginecol Obstet Mex; 1992 Jan; 60():4-7. PubMed ID: 1555790
[TBL] [Abstract][Full Text] [Related]
12. Preventing severe ovarian hyperstimulation syndrome in an in vitro fertilization/embryo transfer program. Use of follicular aspiration after human chorionic gonadotropin administration.
Vrtovec HM; Tomazevic T
J Reprod Med; 1995 Jan; 40(1):37-40. PubMed ID: 7722973
[TBL] [Abstract][Full Text] [Related]
13. [The ovarian hyperstimulation syndrome. Anesthesiologic aspects based on a severe case].
Heylen I; Pichlmayr I; Schlösser HW
Anaesthesist; 1990 Jun; 39(6):330-2. PubMed ID: 2375489
[TBL] [Abstract][Full Text] [Related]
14. Ovarian hyperstimulation syndrome associated with clomiphene citrate.
Mitchell SY; Fletcher HM; Williams E
West Indian Med J; 2001 Sep; 50(3):227-9. PubMed ID: 11769032
[TBL] [Abstract][Full Text] [Related]
15. Serum inhibin A, VEGF and TNFalpha levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial.
Babayof R; Margalioth EJ; Huleihel M; Amash A; Zylber-Haran E; Gal M; Brooks B; Mimoni T; Eldar-Geva T
Hum Reprod; 2006 May; 21(5):1260-5. PubMed ID: 16439507
[TBL] [Abstract][Full Text] [Related]
16. [The Predictive Role of Vascular Endothelial Growth Factor and Estradiol in Infertile Patients with Ovarian Hyperstimulation Syndrome].
Wang Q; Yang G; Yang C; Zhan B; Yang R
Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jul; 34(3):565-7. PubMed ID: 12910723
[TBL] [Abstract][Full Text] [Related]
17. Early and late ovarian hyperstimulation syndrome: early pregnancy outcome and profile.
Papanikolaou EG; Tournaye H; Verpoest W; Camus M; Vernaeve V; Van Steirteghem A; Devroey P
Hum Reprod; 2005 Mar; 20(3):636-41. PubMed ID: 15576388
[TBL] [Abstract][Full Text] [Related]
18. Prevention and treatment of ovarian hyperstimulation syndrome.
Dourron NE; Williams DB
Semin Reprod Endocrinol; 1996 Nov; 14(4):355-65. PubMed ID: 8988530
[TBL] [Abstract][Full Text] [Related]
19. [Coasting and ovarian stimulation protocols in high-responder patients undergoing assisted conception].
Merviel P; Claeys C; Héraud MH; Lourdel E; Lanta S; Barbier F; Nasreddine A
Gynecol Obstet Fertil; 2005 Sep; 33(9):703-12. PubMed ID: 16129645
[TBL] [Abstract][Full Text] [Related]
20. The optimal length of 'coasting protocol' in women at risk of ovarian hyperstimulation syndrome undergoing in vitro fertilization.
Nardo LG; Cheema P; Gelbaya TA; Horne G; Fitzgerald CT; Pease EH; Brison DR; Lieberman BA
Hum Fertil (Camb); 2006 Sep; 9(3):175-80. PubMed ID: 17008270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
